Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL201538 | 1.00 | TSHR (0.48) | TSHRIDO1AGXTALDH1A1L3MBTL1 | |
| SCHEMBL6731394 | 1.00 | TSHR (0.48) | TSHRIDO1AGXTALDH1A1L3MBTL1 | |
| SCHEMBL29284778 | 0.89 | TDP1 (0.43) | TSHRIDO1AGXTALDH1A1L3MBTL1 | |
| SCHEMBL27509183 | 0.85 | TSHR (0.57) | TSHRIDO1AGXTALDH1A1L3MBTL1 | |
| Phosphoric Acid Monomethyl Ester SCHEMBL6825269 | 0.84 | TSHR (0.47) | TSHRALDH1A1RAB9A | |
| SCHEMBL58206 | 0.81 | TSHR (0.52) | TSHRIDO1AGXTALDH1A1L3MBTL1 | |
| SCHEMBL16594360 | 0.80 | TSHR (0.46) | TSHRIDO1AGXTALDH1A1L3MBTL1 | |
| SCHEMBL16594361 | 0.80 | TSHR (0.46) | TSHRIDO1AGXTALDH1A1L3MBTL1 | |
| SCHEMBL11798275 | 0.79 | TSHR (0.50) | TSHRIDO1AGXTALDH1A1L3MBTL1 | |
| SCHEMBL7717208 | 0.78 | IDO1 (0.46) | TSHRIDO1AGXTALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3572402-B1 | LINKED CYCLIC COMPOUND AS CASPASE INHIBITOR | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) | 2022-05-04 | — | — | EP | disclosed |
| US-20190111044-A1 | 2-PHENETHENYLTETRAHYDRO ISOQUINOLINES USEFUL AS ANTI-HIV COMPOUNDS | Prosetta Antiviral, Inc. | 2019-04-18 | — | — | US | disclosed |
| EP-1603414-B1 | ELECTROPROCESSED PHENOLIC MATERIALS AND METHODS | UNIV VIRGINIA COMMONWEALTH (US) | 2017-05-03 | — | — | EP | disclosed |
| US-9196860-B2 | Compounds for triplet-triplet annihilation upconversion | UNIVERSAL DISPLAY CORPORATION (US) | 2015-11-24 | — | — | US | disclosed |
| US-20140151646-A1 | COMPOUNDS FOR TRIPLET-TRIPLET ANNIHILATION UPCONVERSION | UNIVERSAL DISPLAY CORPORATION | 2014-06-05 | — | — | US | disclosed |
| US-8088804-B2 | N-hydroxyamide derivatives possessing antibacterial activity | PFIZER INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-8012399-B2 | Formation of nano-or micro-scale phenolic fibers via electrospinning | PHILIP MORRIS USA INC. (US) | 2011-09-06 | — | — | US | disclosed |
| EP-2338878-A2 | N-hydroxyamide derivatives possessing antibacterial activity | Vicuron Pharmaceuticals, Inc. (US) | 2011-06-29 | — | — | EP | disclosed |
| US-7691843-B2 | N-hydroxyamide derivatives possessing antibacterial activity | PFIZER INC. (US) | 2010-04-06 | — | — | US | disclosed |
| US-20100022605-A1 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. | 2010-01-28 | — | — | US | disclosed |
| EP-1963262-A2 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | Vicuron Pharmaceuticals, Inc. (US) | 2008-09-03 | — | — | EP | disclosed |
| US-20080058304-A1 | N-hydroxyamide derivatives possessing antibacterial activity | VICURON HOLDINGS LLC | 2008-03-06 | — | — | US | disclosed |
| WO-2007069020-A2 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. (US) | 2007-06-21 | — | — | WO | disclosed |
| EP-1539744-A4 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARM INC (US) | 2007-06-06 | — | — | EP | disclosed |
| US-20070035055-A1 | Electroprocessed phenolic materials and methods | PHILIP MORRIS USA INC. | 2007-02-15 | — | — | US | disclosed |
| US-20070020625-A1 | Sequence of the photorhabdus luminescens strain tt01 genome and uses | DUCHAUD ERIC | 2007-01-25 | — | — | US | disclosed |
| EP-1603414-A1 | ELECTROPROCESSED PHENOLIC MATERIALS AND METHODS | Virginia Commonwealth University (US) | 2005-12-14 | — | — | EP | disclosed |
| EP-1539744-A2 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | Vicuron Pharmaceuticals, Inc. (US) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004080217-A1 | ELECTROPROCESSED PHENOLIC MATERIALS AND METHODS | VIRGINIA COMMONWEATH UNIVERSITY (US) | 2004-09-23 | — | — | WO | disclosed |
| WO-2004007444-A2 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS, INC. (US) | 2004-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190111044-A1 | 2-PHENETHENYLTETRAHYDRO ISOQUINOLINES USEFUL AS ANTI-HIV COMPOUNDS | MAVS, EIF2AK2, POLRMT | TSHR 4860/4885IDO1 135/4885AGXT 4118/4885 |
| US-20100022605-A1 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | NAAA, HDHD5, HACL2 | TSHR 3341/4885IDO1 1620/4885AGXT 1307/4885 |
| US-20080058304-A1 | N-hydroxyamide derivatives possessing antibacterial activity | AMDHD2, OGA, ENGASE | TSHR 3540/4885IDO1 390/4885AGXT 520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.